Coexistence of obstructive airway diseases (OAD) in a hospital based sample

H. Firat, S. Ardiç, A. U. Demir, Z. Yildirim, G. Darilmaz Yüce, I. Bardakçi, P. Alagöz (Ankara, Turkey)

Source: Annual Congress 2004 - Assessment of lung diseases
Session: Assessment of lung diseases
Session type: Thematic Poster Session
Number: 1826
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Firat, S. Ardiç, A. U. Demir, Z. Yildirim, G. Darilmaz Yüce, I. Bardakçi, P. Alagöz (Ankara, Turkey). Coexistence of obstructive airway diseases (OAD) in a hospital based sample. Eur Respir J 2004; 24: Suppl. 48, 1826

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A problem based assessment of obstructive airways disease (OAD) in an elderly population
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007


Prevalence of self reported physician diagnosed asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012

The metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD) and its association with airway obstruction
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Longitudinal study of FEO1 as a criterion for bronchial obstruction in outpatients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005

Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

Underutilization of spirometry in the hospital diagnosis of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Aerosol therapies for airway obstructive disorders at home and in the hospital (asthma, COPD, CF and non-CF disorders)
Source: Annual Congress 2010 - The essentials of aerosol therapy: what the practicing physician should know
Year: 2010

Patient’s knowledge about risk factors for acute exacerbation( AE ) of chronic obstructive pulmonary disease( COPD )
Source: Eur Respir J 2004; 24: Suppl. 48, 514s
Year: 2004

Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021